Uptake Patterns of Untreated Primary Gastrointestinal Extranodal Lymphomas on Initial Staging 18F-FDG PET/CT and Metabolic Tumor Parameters
- PMID: 28976330
- PMCID: PMC5643944
- DOI: 10.4274/mirt.48658
Uptake Patterns of Untreated Primary Gastrointestinal Extranodal Lymphomas on Initial Staging 18F-FDG PET/CT and Metabolic Tumor Parameters
Abstract
Objective: Non-Hodgkin's lymphomas arising from tissues other than primary lymphatic sites are classified as primary extranodal lymphomas (PEL). PELs of the gastrointestinal system (PGISL) originate from the lymphatic tissues within the gastrointestinal tract. The prognostic value of 18F-FDG PET/CT in lymphomas is high in terms of both overall survival (OS) and disease-free survival (DFS). Our aim was to investigate the uptake patterns and properties of low-grade and high-grade PGISL on primary staging 18F-FDG PET/CT, as well as the prognostic significance of metabolic tumor parameters in high grade PGISL.
Methods: Thirty-nine patients with PGISL were enrolled in this retrospective cohort study between 2004-2015. Primary staging 18F-FDG PET/CT have been performed and quantitative parameters of SUVmax, SUVmean, metabolic tumor volume (MTV), total lesion glycolysis (TLG) have been calculated for all patients prior to treatment. Low-grade and high-grade PGISL were compared in terms of metabolic tumor parameters. Cox regression models were performed to determine factors that correlate with DFS in high-grade PGISL.
Results: There were statistically significant differences between high-grade and low-grade PGISL in terms of SUVmax, SUVmean, MTV, TLG, recurrence, mortality, DFS and OS. None of the potential risk factors (sex, age, site, SUVmax, SUVmean, MTV, TLG) for recurrence and metastasis in high grade PGISL was identified as a risk factor on univariate and multivariate Cox regression analysis.
Conclusion: Metabolic tumor parameters are not predictive markers in high-grade PGISL, especially in diffuse large B cell variant and primary gastric lymphoma. The first implications suggest they will not play a role in patient management.
Amaç: Primer lenfatik alanlar dışındaki dokulardan kaynaklanan Non-Hodgkin lenfomalara primer ekstranodal lenfoma (PEL) denmektedir. Gastrointestinal sistemin PEL’i (PGISL) buradaki lenfatik dokulardan köken alır. 18F-FDG PET/BT lenfomalarda genel ve hastalıksız sağkalım açısından yüksek prognostik değere sahiptir. Amacımız düşük grad ve yüksek grad PGISL’de primer evreleme 18F-FDG PET/BT’de tutulum şekillerini, özelliklerini, yüksek grad PGISL’de metabolik tümör parametrelerinin prognostik önemi ile birlikte araştırmaktır. Yöntem: 2004-2015 yılları arasında PGISL (evre 1-2) tanısı konmuş 39 hasta bu retrospektif kohort çalışmaya dahil edildi. Hastalara tedaviden önce primer evreleme 18F-FDG PET/BT çekilmiş ve maksimum standardize uptake değeri (SUVmaks), ortalama standardize uptake değeri (SUVortalama), metabolik tümör hacmi (MTV) ve total lezyon glikolizi (TLG) gibi metabolik tümör parametreleri hesaplanmıştı. Düşük grad ve yüksek grad PGISL metabolik tümör parametreleri açısından karşılaştırıldı. Yüksek grad PGISL’de Cox regresyon modelleri üzerinden hastalıksız sağkalım ile ilişkili faktörler tespit edildi. Bulgular: Düşük grad ve yüksek grad PGISL arasında SUVmaks, SUVortalama, MTV, TLG, nüks, mortalite, genel ve hastalıksız sağkalım açısından istatistiksel olarak anlamlı fark saptanmıştır. Yüksek grad PGISL’de nüks ve metastaza etki eden tüm potansiyel risk faktörlerinin (cinsiyet, yaş, site, SUVmaks, SUVortalama, MTV, TLG) tek ve çok değişkenli Cox regresyon analizinden sonra metabolik tümör parametrelerinin bir risk faktörü olmadığı görülmüştür. Sonuç: Metabolik tümör parametreleri özellikle diffüz büyük B hücreli varyant ve primer gastrik lenfoma başta olmak üzere yüksek grade PGISL’nin prognoz tahmininde faydalı değildir. İlk izlenimler hasta yönetiminde bir rolleri olamayacağı yönündedir. Anahtar kelimeler: 18F-fluorodeoksiglukoz pozitron emisyon tomografi/bilgisayarlı tomografi, metabolik tümör parametreleri, primer gastrointestinal lenfoma.
Keywords: 18; F-fluorodeoxyglucose positron emission tomography/computed tomography; metabolic tumor parameters primary gastrointestinal lymphoma..
Conflict of interest statement
Figures



Similar articles
-
Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma.Radiol Oncol. 2016 Sep 8;50(4):360-369. doi: 10.1515/raon-2016-0045. eCollection 2016 Dec 1. Radiol Oncol. 2016. PMID: 27904443 Free PMC article.
-
Can metabolic tumor parameters on primary staging 18F-FDG PET/CT aid in risk stratification of primary central nervous system lymphomas for patient management as a prognostic model?Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jan-Feb;37(1):9-14. doi: 10.1016/j.remn.2017.06.003. Epub 2017 Jul 18. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 28733137 English, Spanish.
-
Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas.Eur J Hybrid Imaging. 2021 Sep 3;5(1):16. doi: 10.1186/s41824-021-00110-5. Eur J Hybrid Imaging. 2021. PMID: 34476632 Free PMC article.
-
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.Clin Nucl Med. 2017 May;42(5):e235-e241. doi: 10.1097/RLU.0000000000001612. Clin Nucl Med. 2017. PMID: 28288043
-
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.Med Oncol. 2015 Jan;32(1):446. doi: 10.1007/s12032-014-0446-1. Epub 2014 Dec 16. Med Oncol. 2015. PMID: 25511321
References
-
- Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, Dhurairaj T, Dadparvar A, Alavi A. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med. 2004;45:1796–1803. - PubMed
-
- Koniaris LG, Drugas G, Katzman PJ, Salloum R. Management of gastrointestinal lymphoma. J Am Coll Surg. 2003;197:127–141. - PubMed
-
- Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, Gaitini D, Israel O. FDG avidity and PET/CT patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging. 2008;35:1424–1430. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources